Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone extension in terminal illness
NCT01367600Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Feb 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Valeant Pharmaceuticals. Started Feb 2003; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01367600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367600.